H3N2 viruses mutate during vaccine production but new tech could fix it - Science Daily

H3N2 viruses mutate during vaccine production but new tech could fix it  Science Daily

A new technology may make H3N2 vaccine development a bit easier. Researchers describe a new cell line that enables better growth of H3N2 for vaccine use.



Comments

Popular posts from this blog

Global Influenzavirus B Infection Drug Market 2019 - AbbVie Inc, Adimmune Corp, Altravax Inc, Amarillo Biosciences Inc, Aphios Corp Business Pulze - Business Pulze

Healthcare layoff tracker—Walmart cuts 74 virtual health jobs - Fierce healthcare